sprodiamide has been researched along with dysprosium in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 22 (91.67) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, PB; Bryan, RN; Conturo, TE; Mathews, VP; Monsein, LH | 1 |
| Higgins, CB; Saeed, M; Wendland, MF | 2 |
| Asgari, H; Kucharczyk, J; Mintorovitch, J; Moseley, M; Rocklage, S; Vexler, Z; Watson, A | 1 |
| Asgari, HS; Derugin, N; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Rocklage, S; Vexler, Z | 1 |
| Higgins, CB; Saeed, M; Wendland, M | 1 |
| Asgari, HS; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Sevick, R; Wendland, MF; White, DL | 1 |
| Kucharczyk, J; Moseley, ME; Norman, D; Quay, SC; Rocklage, SM | 1 |
| Higgins, CB; Moseley, ME; Quay, SC; Rocklage, SM; Saeed, M; Tomei, E; Wendland, MF; Wolfe, C | 1 |
| Nilsson, S | 1 |
| Ericsson, A; Hemmingsson, A; Martinussen, HJ; Nilsson, S; Oksendal, AN; Waldenström, A; Wikström, G; Wikström, M | 1 |
| Ericsson, A; Hemmingsson, A; Nilsson, S; Oksendal, A; Waldenström, A; Wikström, G; Wikström, M | 3 |
| Dommisse, R; Lanens, D; Oksendal, A; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
| Bach-Gansmo, T; Ericsson, A; Hemmingsson, A; Niklasson, F | 1 |
| Godtliebsen, F; Haraldseth, O; Jones, RA; Lindboe, CF; Müller, TB; Sebastiani, G; Unsgård, G | 1 |
| Haraldseth, O; Jones, RA; Müller, TB; Oksendal, AN; Rinck, PA | 1 |
| de Crespigny, AJ; Kucharcyzk, J; Moseley, ME; Roberts, TP | 1 |
| Delos, M; Demeure, R; Goudemant, JF; Jamart, J; Maldague, B; Oksendal, A; Pringot, J; Thiran, JP; Van Beers, BE | 1 |
| Derugin, N; Geschwind, JF; Higgins, CB; Lauerma, K; Saeed, M; Wendland, MF | 1 |
| Arteaga, C; Canet, E; Forrat, R; Hadour, G; Oksendal, A; Revel, D; Zhao, S | 1 |
| Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
| Bach-Gansmo, T; Buzelin, MF; Dupas, B; Karam, G; Meflah, K; Vasse, N | 1 |
1 review(s) available for sprodiamide and dysprosium
| Article | Year |
|---|---|
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
23 other study(ies) available for sprodiamide and dysprosium
| Article | Year |
|---|---|
MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts.
Topics: Animals; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Contrast Media; Dysprosium; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microcirculation; Models, Biological; Models, Chemical; Models, Structural; Organometallic Compounds; Papio; Pentetic Acid; Putamen | 1992 |
Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
Topics: Animals; Brain; Cats; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Time Factors | 1991 |
Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
Contrast enhancement for the myocardium.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid | 1991 |
Ultrafast magnetic resonance imaging: diffusion and perfusion.
Topics: Animals; Brain Ischemia; Cats; Cerebral Arteries; Cerebrovascular Disorders; Contrast Media; Diffusion; Dysprosium; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Perfusion; Time Factors | 1991 |
Early detection of perfusion deficits caused by regional cerebral ischemia in cats. T2-weighted magnetic susceptibility MRI using a nonionic dysprosium contrast agent.
Topics: Animals; Brain Ischemia; Cats; Contrast Media; Dysprosium; Magnetic Resonance Imaging; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Time Factors | 1990 |
Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
Topics: Animals; Blood Pressure; Contrast Media; Coronary Disease; Dysprosium; Heart Rate; Magnetic Resonance Imaging; Muscles; Myocardium; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Rats | 1989 |
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
Dy-DTPA-BMA as an indicator of tissue viability in MR imaging. An experimental study in the pig.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Interactions; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Microdialysis; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors | 1995 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dysprosium; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar; Time Factors | 1995 |
Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Topics: Cell Membrane; Contrast Media; Dysprosium; Erythrocytes; Gadolinium; Gadolinium DTPA; Hematocrit; Humans; Image Enhancement; In Vitro Techniques; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebrovascular Circulation; Contrast Media; Diffusion; Disease Models, Animal; Dysprosium; Frontal Lobe; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Organometallic Compounds; Parietal Lobe; Pentetic Acid; Perfusion; Putamen; Rats; Rats, Wistar; Reperfusion | 1995 |
K-space substitution: a novel dynamic imaging technique.
Topics: Animals; Brain; Brain Ischemia; Contrast Media; Dysprosium; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rats | 1993 |
Improved sensitivity to magnetic susceptibility contrast.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Subtraction Technique | 1993 |
Myocardial cell death in reperfused and nonreperfused myocardial infarctions. MR imaging with dysprosioum-DTPA-BMA in the pig.
Topics: Animals; Cell Death; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Image Enhancement; Injections, Intravenous; Intestines; Ischemia; Magnetic Resonance Imaging; Male; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1997 |
AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Topics: Animals; Awards and Prizes; Cell Death; Contrast Media; Drug Evaluation, Preclinical; Dysprosium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Dysprosium; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid | 1999 |
Contrast-enhanced MR imaging of experimental acute tubular necrosis.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Combinations; Dysprosium; Gadolinium DTPA; Injections, Intravenous; Kidney Medulla; Kidney Tubular Necrosis, Acute; Kidney Tubules; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred BN | 2001 |